Optomed Oyj (HEL:OPTOMED)

Market Cap	35.60M -51.5%
Revenue (ttm)	16.10M +0.1%
Net Income	-5.45M
EPS	-0.27
Shares Out	21.47M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,256
Open	1.678
Previous Close	1.658
Day's Range	1.620 - 1.680
52-Week Range	1.332 - 4.330
Beta	1.57
Analysts	Hold
Price Target	2.37 (+46.3%)
Earnings Date	Aug 14, 2026

About Optomed Oyj

Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally. The company operates in two segments, Devices and Software. It develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary health care professionals; and provides professional IT consulting services for government institutions. The company also provides camera products under the Optomed Smartscope Pro, Optomed Aurora, Optomed Aurora AEYE...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2004
• Employees: 110
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: OPTOMED

Financial Performance

In 2025, Optomed Oyj's revenue was 17.10 million, an increase of 13.67% compared to the previous year's 15.04 million. Losses were -6.64 million, 21.8% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for OPTOMED stock is "Hold." The 12-month stock price target is €2.37, which is an increase of 46.30% from the latest price.

Price Target

€2.37

(46.30% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 1, 2026

Data Sources Report a data error